tiprankstipranks
Viemed Healthcare Inc (VMD)
NASDAQ:VMD
Want to see VMD full AI Analyst Report?

Viemed Healthcare (VMD) Price & Analysis

180 Followers

VMD Stock Chart & Stats

$11.76
$0.11(0.94%)
At close: 4:00 PM EDT
$11.76
$0.11(0.94%)

Bulls Say, Bears Say

Bulls Say
High Gross And EBITDA MarginsSustained high gross margins and stable EBITDA margins indicate durable pricing power and efficient service delivery in home respiratory care. This margin profile supports reinvestment in patient programs, funds expansion, and provides a buffer against reimbursement pressure over the next several quarters.
Conservative Balance Sheet And LiquidityVery low leverage and available credit provide financial flexibility to fund growth, acquisitions and working-capital variability. The reduced long-term debt and liquidity cushion lower refinancing risk and support continued capital returns or investment without stressing operations over the medium term.
Diversifying Revenue Mix And Growth VectorsMeaningful expansion in sleep (PAP), equipment/supply sales and maternal health reduces concentration in ventilator rentals, improves recurring resupply revenue, and enhances capital efficiency. A broader, growing service mix supports steadier revenue and lowers dependency on any single reimbursement or product cohort.
Bears Say
Ventilator Census And Policy-driven Access RiskNCD-driven compliance and higher turnover create ongoing structural risk to ventilator rental volumes, which historically represent a large share of revenue. Reduced net census can materially lower recurring rental streams and increase acquisition costs to replace churned patients over multiple quarters.
Volatile Free Cash Flow ConversionInconsistent free cash flow conversion, despite a TTM improvement, signals sensitivity to working-capital swings and investment timing. Less reliable FCF constrains internal funding for growth and makes capital allocation (debt paydown, buybacks, acquisitions) more dependent on executed cash-cycle improvements.
Rising Absolute SG&A From Growth And AcquisitionsIncreasing absolute SG&A tied to headcount and integration costs can limit bottom-line conversion despite healthy gross margins. If SG&A growth outpaces scalable revenue gains, net margins (~5–6% recently) may remain compressed, reducing free cash generation and earnings resilience over coming quarters.

Viemed Healthcare News

VMD FAQ

What was Viemed Healthcare Inc’s price range in the past 12 months?
Viemed Healthcare Inc lowest stock price was $5.93 and its highest was $12.61 in the past 12 months.
    What is Viemed Healthcare Inc’s market cap?
    Viemed Healthcare Inc’s market cap is $446.62M.
      When is Viemed Healthcare Inc’s upcoming earnings report date?
      Viemed Healthcare Inc’s upcoming earnings report date is Aug 03, 2026 which is in 3 days.
        How were Viemed Healthcare Inc’s earnings last quarter?
        Viemed Healthcare Inc released its earnings results on May 05, 2026. The company reported $0.06 earnings per share for the quarter, missing the consensus estimate of $0.09 by -$0.03.
          Is Viemed Healthcare Inc overvalued?
          According to Wall Street analysts Viemed Healthcare Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Viemed Healthcare Inc pay dividends?
            Viemed Healthcare Inc does not currently pay dividends.
            What is Viemed Healthcare Inc’s EPS estimate?
            Viemed Healthcare Inc’s EPS estimate is 0.12.
              How many shares outstanding does Viemed Healthcare Inc have?
              Viemed Healthcare Inc has 38,336,803 shares outstanding.
                What happened to Viemed Healthcare Inc’s price movement after its last earnings report?
                Viemed Healthcare Inc reported an EPS of $0.06 in its last earnings report, missing expectations of $0.09. Following the earnings report the stock price went down -12.216%.
                  Which hedge fund is a major shareholder of Viemed Healthcare Inc?
                  Currently, no hedge funds are holding shares in VMD
                  What is the TipRanks Smart Score and how is it calculated?
                  Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

                    Company Description

                    Viemed Healthcare Inc

                    Viemed Healthcare, Inc., through its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The company provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. It also sells and rents HME devices, such as non-invasive and invasive ventilators, positive airway pressure (PAP) machines, durable medical equipment, percussion vests, oxygen concentrators, and other medical equipment. In addition, the company provides neuromuscular care and oxygen therapy services; and sleep apnea management which provides sleep solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, it offers in-home sleep apnea testing services; and breast pumps and related lactation equipment and supplies, including fulfillment and support services, as well as healthcare staffing and recruitment services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.

                    Viemed Healthcare (VMD) Earnings & Revenues

                    VMD Company Deck

                    VMD Earnings Call

                    Q1 2026
                    0:00 / 0:00
                    Earnings Call Sentiment|Positive
                    The call presented strong operational and financial progress: revenue growth of 28% YoY, substantial free cash flow improvement, meaningful scaling in sleep (PAP up 57% YoY) and maternal health expansion, improved capital efficiency and a stronger, more diversified revenue mix. Near-term headwinds are largely related to NCD-driven compliance effects in ventilation (higher turnover and temporary pressure on net census), some seasonality, and comparability issues from a prior-year gain. Management reiterated positive guidance, tightened revenue guidance upward, and highlighted continued margin and cash-flow improvement, indicating confidence in execution.View all VMD earnings summaries
                    Similar Stocks
                    Company
                    Price & Change
                    Follow
                    Inogen
                    Senseonics Holdings
                    Tactile Systems Technology
                    Outset Medical
                    Bioventus

                    Ownership Overview

                    13.67%13.07%1.64%62.99%
                    13.67% Insiders
                    1.64% Other Institutional Investors
                    62.99% Public Companies and
                    Individual Investors
                    Popular Stocks